We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.63%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$39.7M +$35.9M +728,555 New
Tudor Investment Corp
27
Tudor Investment Corp
Connecticut
$38.4M +$34.8M +705,824 New
JCI
28
Jet Capital Investors
New York
$38.1M +$34.5M +700,000 New
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$38M +$34.4M +697,590 New
Franklin Resources
30
Franklin Resources
California
$37.1M +$33.6M +681,760 New
Macquarie Group
31
Macquarie Group
Australia
$33.1M +$29.9M +607,873 New
AA
32
AQR Arbitrage
Connecticut
$32.6M +$29.5M +598,525 New
PC
33
PointState Capital
New York
$31.9M +$28.9M +586,551 New
CWM
34
CIBC World Markets
New York
$28.8M +$26.1M +529,500 New
Deutsche Bank
35
Deutsche Bank
Germany
$27.6M +$25M +506,659 New
TCIM
36
TIAA CREF Investment Management
New York
$26.9M +$24.3M +494,200 New
Bank of America
37
Bank of America
North Carolina
$25.9M +$23.4M +475,058 New
CWAM
38
Columbia Wanger Asset Management
Illinois
$25.8M +$23.3M +473,000 New
NCMU
39
NAYA Capital Management (UK)
United Kingdom
$25.4M +$23M +466,641 New
Legal & General Group
40
Legal & General Group
United Kingdom
$24M +$21.7M +440,078 New
Principal Financial Group
41
Principal Financial Group
Iowa
$23.7M +$21.5M +435,600 New
Westfield Capital Management
42
Westfield Capital Management
Massachusetts
$23.4M +$21.1M +428,834 New
EVM
43
Eaton Vance Management
Massachusetts
$22.6M +$20.4M +414,880 New
Charles Schwab
44
Charles Schwab
California
$22.5M +$20.3M +413,073 New
Goldman Sachs
45
Goldman Sachs
New York
$22.4M +$20.2M +410,807 New
N
46
Natixis
France
$22.1M +$20M +405,111 New
Russell Investments Group
47
Russell Investments Group
United Kingdom
$21.4M +$19.4M +393,756 New
YCMGA
48
York Capital Management Global Advisors
New York
$20.4M +$18.5M +374,930 New
JHIU
49
Janus Henderson Investors US
Colorado
$19.6M +$17.7M +359,675 New
GC
50
Guggenheim Capital
Illinois
$19.2M +$17.3M +352,212 New
1
2
3 4 5

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.